相关实验视频
Updated: May 27, 2025

23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
7.9K
帕金森病的神经损伤因子:目前的状况,进展和剩余问题. 来自2023年研讨会的结论
Roger A Barker1, Mart Saarma2, Clive N Svendsen3
1Department of Clinical Neurosciences and Cambridge Stem Cell Institute, John van Geest Centre for Brain Repair, Forvie Site, Cambridge, UK.
Journal of Parkinson's disease
|February 17, 2025
概括
这次研讨会回顾了帕金森病 (PD) 的生长因子 (GF),讨论了新的数据,传递方法和试验设计. 为未来的GFPD研究提出了建议.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
背景情况:
- 2019年的一次研讨会确定了生长因子 (GFs) 作为帕金森病 (PD) 的有希望的治疗途径.
- 自2019年以来,GF研究取得了重大进展,包括新的治疗剂和改进的研究模型.
研究的目的:
- 对帕金森病的生长因子研究的最新进展进行审查和综合.
- 讨论关于GF传递,组合疗法和PD临床试验设计的新见解.
主要方法:
- 2023年的研讨会召集了来自治疗帕金森病,迈克尔·J·福克斯基金会和帕金森病英国的专家.
- 讨论包括对已完成的GDNF和CDNF试验的分析,包括患者的观点.
- 评估关于GF发育,疾病模型和治疗调制策略的新数据.
主要成果:
- 在开发新的生长因子和完善PD研究疾病模型方面取得了进展.
- 从GDNF和CDNF试验中强调了关于交付,患者体验和试验参数的关键学习.
- 认识到组合疗法和调制治疗帕金森病的潜力.
结论:
- 对帕金森病的生长因子研究需要用精细的方法进行持续的调查.
- 未来的研究应该结合最近的试验,患者反和先进的治疗策略的见解.
- 制定了建议,以指导帕金森病研究中生长因子研究的进展.
相关概念视频
Parkinson's Disease: Overview
429
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
429
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Treatment
187
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
187

